Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests

Researchers at the University of Michigan Health Rogel Cancer Center have developed a new approach to suppress prostate cancer growth in preclinical tests, demonstrating greater antitumor activity while sparing normal cells.